UPDATED May 04, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
AXP | US$230.77 | -0.7% | 51.2% | US$166.0b | US$228.74 | PE18.7x | E7.8% | 1.2% | Diversified Financials | ||
PYPL | US$65.70 | -1.9% | -12.4% | US$68.7b | US$76.57 | PE15.8x | E4.1% | n/a | Diversified Financials | ||
COIN | US$223.25 | -2.4% | 283.3% | US$54.8b | US$248.18 | PE40.6x | E-14.6% | n/a | Diversified Financials | ||
APO | US$109.46 | -2.3% | 80.8% | US$62.3b | US$124.77 | PE11.9x | E5.1% | 1.7% | Diversified Financials | ||
JNJ | US$149.27 | -0.4% | -8.2% | US$359.2b | US$173.26 | PE21x | E7.0% | 3.3% | Pharmaceuticals & Biotech | ||
BDX | US$234.68 | -2.4% | -7.5% | US$67.8b | US$278.32 | PE49.7x | E17.8% | 1.6% | Healthcare | ||
KKR | US$95.01 | -2.2% | 84.4% | US$84.1b | US$115.42 | PE20.8x | E8.2% | 0.7% | Diversified Financials | ||
MRK | US$127.51 | -0.6% | 8.4% | US$323.0b | US$141.64 | PE140.1x | E24.9% | 2.4% | Pharmaceuticals & Biotech | ||
SBUX | US$73.11 | -2.4% | -31.8% | US$82.8b | US$90.62 | PE19.9x | E9.4% | 3.1% | Consumer Services | ||
MCD | US$270.32 | -1.1% | -8.9% | US$195.2b | US$315.33 | PE22.7x | E6.6% | 2.5% | Consumer Services | ||
IR | US$86.72 | -6.6% | 46.6% | US$35.0b | US$98.58 | PE42.7x | E14.8% | 0.09% | Capital Goods | ||
EXPE | US$115.33 | -15.3% | 23.3% | US$15.3b | US$152.26 | PE18.9x | E17.8% | 0% | Consumer Services | ||
VMW | US$142.48 | -5.0% | 19.4% | US$61.5b | US$158.83 | PE43.1x | E14.2% | n/a | Software | ||
JPM | US$190.51 | -0.6% | 39.3% | US$547.1b | US$207.83 | PB1.8x | E-1.3% | 2.4% | Banks | ||
NET | US$74.40 | -16.4% | 68.8% | US$25.3b | US$93.33 | PS18.3x | E23.9% | n/a | Software | ||
FTNT | US$58.88 | -9.7% | -8.8% | US$44.9b | US$72.52 | PE37.5x | E13.3% | n/a | Software | ||
BRK.A | US$603,000.00 | -0.6% | 22.6% | US$865.4b | US$669,078.00 | PE9x | E-35.3% | n/a | Diversified Financials | ||
LLY | US$734.97 | -2.8% | 71.8% | US$661.8b | US$848.35 | PE107.8x | E27.0% | 0.7% | Pharmaceuticals & Biotech |